Skip to content

BRAIDWELL LP

Follow

13F filer, CIK 1920938, STAMFORD, CT

BRAIDWELL LP reported $2,409,466,201 across 88 holdings for the quarter ended 2026-09-30, in a 13F-HR filed 2026-11-16. Its ten largest share positions make up 30.72% of the portfolio.

Accepted , ingested 13F-HR 0001420506-26-002894

Period
2026-09-30
Reported value
$2.41B
Holdings
88
Top 10 weight
30.72%
New
16
Sold out
14

Largest buys vs the previous quarter

SecurityShares changeApprox. value
VERAadded+1,161,969$37.5M
DMRAnew+1,747,659$37.2M
NVCTnew+1,573,823$33.2M
TEVAnew+753,537$29.8M
ISRGadded+55,820$22.7M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
CAIreduced-5,509,344-$169M
KODreduced-701,575-$66.5M
HNGEreduced-674,821-$65.6M
DMRAexited-1,620,377-$42.1M
ACADexited-1,646,399-$41.7M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2026

Share positions as resolved from 13F-HR 0001420506-26-002894, largest first. % of portfolio is the value over $2,409,466,201, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
KODKODIAK SCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 2,072,788 shares; 2026Q1: 1,818,665 shares; 2026Q2: 1,787,318 shares; 2026Q3: 1,085,743 shares 1,085,743$103M4.27%-701,575Timeline
CAICARIS LIFE SCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 7,316,142 shares; 2025Q3: 7,316,142 shares; 2025Q4: 7,816,142 shares; 2026Q1: 8,009,447 shares; 2026Q2: 8,256,032 shares; 2026Q3: 2,746,688 shares 2,746,688$84.1M3.49%-5,509,344Timeline
EWTXEDGEWISE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,332,196 shares; 2025Q1: 2,458,808 shares; 2025Q2: 5,210,831 shares; 2025Q3: 5,210,831 shares; 2025Q4: 5,210,831 shares; 2026Q1: 2,347,583 shares; 2026Q2: 1,996,965 shares; 2026Q3: 2,069,091 shares 2,069,091$84M3.49%+72,126Timeline
ATECALPHATEC HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 4,256,490 shares; 2025Q1: 4,259,429 shares; 2025Q2: 3,635,172 shares; 2025Q3: 1,514,604 shares; 2025Q4: not reported; 2026Q1: 2,172,725 shares; 2026Q2: 6,531,439 shares; 2026Q3: 7,228,839 shares 7,228,839$74.6M3.1%+697,400Timeline
IRTCIRHYTHM HOLDINGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 705,391 shares; 2025Q1: 556,391 shares; 2025Q2: 300,029 shares; 2025Q3: 225,845 shares; 2025Q4: 217,345 shares; 2026Q1: 610,192 shares; 2026Q2: 654,262 shares; 2026Q3: 640,562 shares 640,562$72.8M3.02%-13,700Timeline
HNGEHINGE HEALTH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 910,476 shares; 2025Q4: 1,304,623 shares; 2026Q1: 1,455,123 shares; 2026Q2: 1,330,127 shares; 2026Q3: 655,306 shares 655,306$63.7M2.64%-674,821Timeline
SYRESPYRE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,578,404 shares; 2025Q1: 2,578,404 shares; 2025Q2: 2,578,404 shares; 2025Q3: 2,578,404 shares; 2025Q4: 1,634,615 shares; 2026Q1: 932,823 shares; 2026Q2: 879,467 shares; 2026Q3: 713,957 shares 713,957$63.6M2.64%-165,510Timeline
XENEXENON PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,913,964 shares; 2025Q1: 2,709,875 shares; 2025Q2: 3,605,029 shares; 2025Q3: 3,605,029 shares; 2025Q4: 1,825,076 shares; 2026Q1: 1,338,452 shares; 2026Q2: 1,131,452 shares; 2026Q3: 1,708,435 shares 1,708,435$63.5M2.64%+576,983Timeline
NEONEOGENOMICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 1,771,146 shares; 2025Q4: 4,632,801 shares; 2026Q1: 5,617,402 shares; 2026Q2: 4,918,202 shares; 2026Q3: 3,348,502 shares 3,348,502$61.5M2.55%-1,569,700Timeline
GKOSGLAUKOS CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 288,876 shares; 2025Q1: 624,435 shares; 2025Q2: 603,414 shares; 2025Q3: 780,164 shares; 2025Q4: 921,979 shares; 2026Q1: 763,505 shares; 2026Q2: 591,927 shares; 2026Q3: 343,873 shares 343,873$56.5M2.34%-248,054Timeline
VERAVERA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 472,739 shares; 2025Q4: 784,742 shares; 2026Q1: 523,824 shares; 2026Q2: 564,724 shares; 2026Q3: 1,726,693 shares 1,726,693$55.8M2.31%+1,161,969Timeline
TMDXTRANSMEDICS GROUP INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 922,100 shares; 2025Q1: 854,884 shares; 2025Q2: 255,048 shares; 2025Q3: 351,248 shares; 2025Q4: 315,341 shares; 2026Q1: 329,391 shares; 2026Q2: 609,715 shares; 2026Q3: 654,178 shares 654,178$54.6M2.27%+44,463Timeline
ISRGINTUITIVE SURGICAL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 75,300 shares; 2025Q1: 88,000 shares; 2025Q2: 89,600 shares; 2025Q3: 130,227 shares; 2025Q4: 83,417 shares; 2026Q1: 77,297 shares; 2026Q2: 70,137 shares; 2026Q3: 125,957 shares 125,957$51.2M2.13%+55,820Timeline
AVAHAVEANNA HEALTHCARE HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 2,203,506 shares; 2026Q2: 3,065,106 shares; 2026Q3: 3,870,106 shares 3,870,106$48M1.99%+805,000Timeline
NBIXNEUROCRINE BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 901,790 shares; 2025Q1: 1,191,925 shares; 2025Q2: 1,160,425 shares; 2025Q3: 880,282 shares; 2025Q4: 751,534 shares; 2026Q1: 652,121 shares; 2026Q2: 336,171 shares; 2026Q3: 336,571 shares 336,571$47.7M1.98%+400Timeline
DNTHDIANTHUS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,206,589 shares; 2025Q1: 375,355 shares; 2025Q2: not reported; 2025Q3: 835,057 shares; 2025Q4: 1,273,935 shares; 2026Q1: 899,364 shares; 2026Q2: 594,562 shares; 2026Q3: 518,398 shares 518,398$45.6M1.89%-76,164Timeline
BTSGBRIGHTSPRING HEALTH SVCS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,195,786 shares; 2026Q1: 1,016,562 shares; 2026Q2: 596,753 shares; 2026Q3: 802,472 shares 802,472$45.5M1.89%+205,719Timeline
GENBGENERATE BIOMEDICINES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 3,592,999 shares; 2026Q2: 3,283,844 shares; 2026Q3: 2,962,249 shares 2,962,249$44.5M1.85%-321,595Timeline
MRVIMARAVAI LIFESCIENCES HLDGS IQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 8,353,287 shares; 2025Q1: 8,353,287 shares; 2025Q2: 8,353,287 shares; 2025Q3: 8,353,287 shares; 2025Q4: 8,353,287 shares; 2026Q1: 10,240,164 shares; 2026Q2: 8,702,921 shares; 2026Q3: 5,503,086 shares 5,503,086$42.2M1.75%-3,199,835Timeline
KRYSKRYSTAL BIOTECH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 200,500 shares; 2025Q1: 400,744 shares; 2025Q2: 727,811 shares; 2025Q3: 520,401 shares; 2025Q4: 202,101 shares; 2026Q1: 182,425 shares; 2026Q2: 128,975 shares; 2026Q3: 114,077 shares 114,077$37.9M1.57%-14,898Timeline
ACHCACADIA HEALTHCARE COMPANY INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 645,900 shares; 2026Q2: 1,141,477 shares; 2026Q3: 1,352,693 shares 1,352,693$37.2M1.54%+211,216Timeline
DMRADAMORA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 1,747,659 shares 1,747,659$37.2M1.54%newTimeline
ALMRALAMAR BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 1,083,983 shares; 2026Q3: 1,083,983 shares 1,083,983$36.9M1.53%0Timeline
KYMRKYMERA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 276,692 shares; 2025Q4: 454,259 shares; 2026Q1: 337,559 shares; 2026Q2: 378,163 shares; 2026Q3: 300,569 shares 300,569$33.6M1.39%-77,594Timeline
NVCTNUVECTIS PHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 1,573,823 shares 1,573,823$33.2M1.38%newTimeline
CLYMCLIMB BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,529,675 shares; 2026Q2: 2,797,375 shares; 2026Q3: 2,863,350 shares 2,863,350$32.8M1.36%+65,975Timeline
INSPINSPIRE MED SYS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 293,410 shares; 2025Q1: 302,410 shares; 2025Q2: 522,410 shares; 2025Q3: 883,747 shares; 2025Q4: 540,890 shares; 2026Q1: 677,570 shares; 2026Q2: 677,570 shares; 2026Q3: 464,470 shares 464,470$32.2M1.34%-213,100Timeline
DHRDANAHER CORP DELQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 309,339 shares; 2025Q2: 309,339 shares; 2025Q3: 309,339 shares; 2025Q4: 118,227 shares; 2026Q1: 139,327 shares; 2026Q2: 150,627 shares; 2026Q3: 141,504 shares 141,504$31.4M1.3%-9,123Timeline
MAZEMAZE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 1,140,040 shares; 2026Q3: 1,149,735 shares 1,149,735$31.2M1.3%+9,695Timeline
HUMHUMANA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 114,500 shares; 2026Q3: 81,399 shares 81,399$31.1M1.29%-33,101Timeline
GLUEMONTE ROSA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 948,316 shares; 2026Q1: 3,206,574 shares; 2026Q2: 2,451,562 shares; 2026Q3: 2,526,009 shares 2,526,009$30.1M1.25%+74,447Timeline
TEVATEVA PHARMACEUTICAL INDS LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 753,537 shares 753,537$29.8M1.24%newTimeline
TMOTHERMO FISHER SCIENTIFIC INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 89,754 shares; 2025Q1: 127,733 shares; 2025Q2: 135,233 shares; 2025Q3: 113,933 shares; 2025Q4: 80,725 shares; 2026Q1: 92,915 shares; 2026Q2: 89,395 shares; 2026Q3: 41,675 shares 41,675$28.1M1.17%-47,720Timeline
IMCRIMMUNOCORE HLDGS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 521,327 shares; 2026Q3: 906,115 shares 906,115$27.4M1.14%+384,788Timeline
NKTRNEKTAR THERAPEUTICSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 222,701 shares; 2026Q2: 473,617 shares; 2026Q3: 443,591 shares 443,591$26.9M1.11%-30,026Timeline
ORKAORUKA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,147,676 shares; 2025Q1: 1,572,426 shares; 2025Q2: 1,524,842 shares; 2025Q3: 1,382,350 shares; 2025Q4: 84,795 shares; 2026Q1: not reported; 2026Q2: 278,164 shares; 2026Q3: 319,679 shares 319,679$26.6M1.11%+41,515Timeline
BSXBOSTON SCIENTIFIC CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 346,467 shares; 2026Q2: 587,567 shares; 2026Q3: 587,567 shares 587,567$25.6M1.06%0Timeline
NTRANATERA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 111,500 shares; 2026Q1: 129,000 shares; 2026Q2: 79,500 shares; 2026Q3: 59,900 shares 59,900$24.8M1.03%-19,600Timeline
EOLSEVOLUS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 3,105,209 shares; 2026Q1: 3,105,209 shares; 2026Q2: 3,155,209 shares; 2026Q3: 3,084,022 shares 3,084,022$24.7M1.02%-71,187Timeline
AVTXAVALO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 1,629,182 shares; 2026Q3: 1,609,392 shares 1,609,392$24.7M1.02%-19,790Timeline
KIDSORTHOPEDIATRICS CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,107,770 shares; 2025Q1: 1,107,770 shares; 2025Q2: 1,107,770 shares; 2025Q3: 1,107,770 shares; 2025Q4: 1,100,370 shares; 2026Q1: 1,100,370 shares; 2026Q2: 1,100,370 shares; 2026Q3: 1,100,370 shares 1,100,370$24.5M1.02%0Timeline
RYTMRHYTHM PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 310,628 shares; 2026Q2: 381,128 shares; 2026Q3: 255,828 shares 255,828$24.4M1.01%-125,300Timeline
DRUGBRIGHT MINDS BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 303,685 shares; 2025Q4: 324,358 shares; 2026Q1: 539,708 shares; 2026Q2: 483,822 shares; 2026Q3: 483,822 shares 483,822$24.1M1%0Timeline
MBXMBX BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,018,600 shares; 2026Q1: 1,492,467 shares; 2026Q2: 710,880 shares; 2026Q3: 398,951 shares 398,951$23.4M0.97%-311,929Timeline
CRVSCORVUS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,752,798 shares; 2026Q2: 2,126,298 shares; 2026Q3: 1,931,402 shares 1,931,402$22.2M0.92%-194,896Timeline
RGENREPLIGEN CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 283,823 shares; 2025Q1: 81,656 shares; 2025Q2: 144,556 shares; 2025Q3: 195,656 shares; 2025Q4: 81,790 shares; 2026Q1: 47,500 shares; 2026Q2: 177,100 shares; 2026Q3: 111,500 shares 111,500$21.4M0.89%-65,600Timeline
AVLNAVALYN PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 801,395 shares; 2026Q3: 744,460 shares 744,460$21.2M0.88%-56,935Timeline
GHRSGH RESEARCH PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 207,240 shares; 2026Q3: 902,815 shares 902,815$21.2M0.88%+695,575Timeline
GHGUARDANT HEALTH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,847,931 shares; 2025Q1: 1,327,327 shares; 2025Q2: 837,800 shares; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 499,712 shares; 2026Q2: 147,850 shares; 2026Q3: 117,910 shares 117,910$21M0.87%-29,940Timeline
NRIXNURIX THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 2,183,864 shares; 2026Q1: 1,750,766 shares; 2026Q2: 1,286,769 shares; 2026Q3: 871,104 shares 871,104$20.7M0.86%-415,665Timeline
CSTLCASTLE BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 365,247 shares; 2025Q2: 822,735 shares; 2025Q3: 822,735 shares; 2025Q4: 177,183 shares; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 502,508 shares 502,508$17.9M0.74%newTimeline
OVIDOVID THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 5,919,464 shares; 2026Q3: 6,582,421 shares 6,582,421$16.4M0.68%+662,957Timeline
SYKSTRYKER CORPORATIONQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 49,560 shares 49,560$13.6M0.57%newTimeline
ORICORIC PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,128,040 shares; 2026Q2: 1,214,540 shares; 2026Q3: 990,959 shares 990,959$13.3M0.55%-223,581Timeline
SEPNSEPTERNA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 328,240 shares 328,240$12.8M0.53%newTimeline
COGTCOGENT BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 400,913 shares 400,913$12.8M0.53%newTimeline
ANLADLAI NORTYE GROUP LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 795,214 shares; 2026Q3: 795,214 shares 795,214$12.7M0.53%0Timeline
LFSTLIFESTANCE HEALTH GROUP INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 975,385 shares 975,385$11.7M0.49%newTimeline
ZURAZURA BIO LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,472,806 shares; 2025Q1: 2,472,806 shares; 2025Q2: 2,472,806 shares; 2025Q3: 2,472,806 shares; 2025Q4: 3,180,389 shares; 2026Q1: 3,988,989 shares; 2026Q2: 3,980,295 shares; 2026Q3: 2,652,991 shares 2,652,991$11M0.46%-1,327,304Timeline
SRZNSURROZEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 140,000 shares; 2025Q3: 140,000 shares; 2025Q4: 470,000 shares; 2026Q1: 396,100 shares; 2026Q2: 390,753 shares; 2026Q3: 335,206 shares 335,206$10.8M0.45%-55,547Timeline
ETRAELECTRA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 905,731 shares 905,731$10.2M0.42%newTimeline
OCSOCULIS HOLDING AGQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 834,183 shares; 2026Q3: 1,068,883 shares 1,068,883$9.98M0.41%+234,700Timeline
SPTXSEAPORT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 500,000 shares; 2026Q3: 481,489 shares 481,489$9.71M0.4%-18,511Timeline
HLXCHELIX ACQUISITION CORP IIIQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 900,000 shares; 2026Q2: 900,000 shares; 2026Q3: 900,000 shares 900,000$9.47M0.39%0Timeline
DGXQUEST DIAGNOSTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 43,200 shares; 2026Q3: 40,400 shares 40,400$9.42M0.39%-2,800Timeline
ACRSACLARIS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,699,116 shares; 2026Q2: 2,142,348 shares; 2026Q3: 1,753,978 shares 1,753,978$9.23M0.38%-388,370Timeline
TECXTECTONIC THERAPEUTIC INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 736,867 shares; 2025Q4: 927,524 shares; 2026Q1: 847,151 shares; 2026Q2: 596,900 shares; 2026Q3: 371,102 shares 371,102$8.64M0.36%-225,798Timeline
IONSIONIS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 130,862 shares; 2026Q2: 116,762 shares; 2026Q3: 176,462 shares 176,462$7.88M0.33%+59,700Timeline
ELVELEVANCE HEALTH INC FORMERLYQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 62,080 shares; 2026Q2: 53,960 shares; 2026Q3: 19,440 shares 19,440$7.56M0.31%-34,520Timeline
YARWYARROW BIOSCIENCE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 331,400 shares 331,400$7.46M0.31%newTimeline
AMANAMANAT ACQUISITION CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 700,000 shares; 2026Q3: 700,000 shares 700,000$7.46M0.31%0Timeline
BIOABIOAGE LABS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,200,587 shares; 2026Q2: 1,033,129 shares; 2026Q3: 1,033,129 shares 1,033,129$7.32M0.3%0Timeline
XFORX4 PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 3,368,904 shares; 2026Q1: 3,272,954 shares; 2026Q2: 2,922,754 shares; 2026Q3: 2,344,822 shares 2,344,822$6.8M0.28%-577,932Timeline
VORVOR BIOPHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 466,774 shares; 2026Q2: 573,104 shares; 2026Q3: 319,308 shares 319,308$6.09M0.25%-253,796Timeline
IMUXIMMUNIC INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 645,010 shares; 2026Q3: 645,110 shares 645,110$6M0.25%+100Timeline
ADRXADARX PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 300,000 shares 300,000$5.98M0.25%newTimeline
QUREUNIQURE NVQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 301,652 shares; 2026Q3: 226,652 shares 226,652$5.48M0.23%-75,000Timeline
RACCRESEARCH ALLIANCE CORP IIIQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 400,000 shares; 2026Q3: 400,000 shares 400,000$4.28M0.18%0Timeline
JTTTJATT III ACQUISITION CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 350,000 shares 350,000$3.91M0.16%newTimeline
ATTOATTOVIA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 225,000 shares 225,000$3.86M0.16%newTimeline
RACDRESEARCH ALLIANCE CORP IVQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 300,000 shares 300,000$3.55M0.15%newTimeline
CGONCG ONCOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 3,283,317 shares; 2025Q1: 3,283,317 shares; 2025Q2: 3,283,317 shares; 2025Q3: 3,283,317 shares; 2025Q4: 1,870,571 shares; 2026Q1: 984,783 shares; 2026Q2: not reported; 2026Q3: 41,100 shares 41,100$2.91M0.12%newTimeline
JATTJATT II ACQUISITION CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 250,000 shares; 2026Q3: 250,000 shares 250,000$2.78M0.12%0Timeline
LUNGPULMONX CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 752,541 shares; 2025Q1: 752,541 shares; 2025Q2: 752,541 shares; 2025Q3: 752,541 shares; 2025Q4: 752,541 shares; 2026Q1: 752,541 shares; 2026Q2: 752,541 shares; 2026Q3: 752,541 shares 752,541$1.44M0.06%0Timeline
KRSAKORSANA BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 43,042 shares 43,042$1.38M0.06%newTimeline
TENXTENAX THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 584,412 shares; 2026Q3: 584,412 shares 584,412$1.1M0.05%0Timeline

Principal amounts

Notes and convertibles filed as a face amount (PRN). A face amount is never added to a share count (H6).

SecurityTypeAmountValueChange
ALPHATEC HLDGS INCALPHATEC HLDGS INC NOTE 0.750% 3/1principal69,121,000$69.3M0
NEOGENOMICS INCNEOGENOMICS INC NOTE 0.250% 1/1principal18,011,000$16.9M0

Sold out in Q3 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
DMRADAMORA THERAPEUTICS INC1,620,377$42.1Mshares
ACADACADIA PHARMACEUTICALS INC1,646,399$41.7Mshares
CDNACAREDX INC1,220,602$34.8Mshares
DYNDYNE THERAPEUTICS INC921,598$20.5Mshares
REPLIGEN CORPREPLIGEN CORP16,000,000$16.4Mprincipal
ARGXARGENX SE17,707$16.4Mshares
CLDXCELLDEX THERAPEUTICS INC NEW436,646$16.2Mshares
MNKDMANNKIND CORP3,458,429$14.7Mshares
KNSAKINIKSA PHARMACEUTICALS INTL183,822$11.8Mshares
KARDKARDIGAN INC300,000$7.16Mshares
COAGHEMAB THERAPEUTICS HLDGS INC160,000$5.88Mshares
WATWATERS CORP14,040$5.27Mshares
VYNEVYNE THERAPEUTICS INC916,077$596Kshares
CYCNCYCLERION THERAPEUTICS INC156,890$532Kshares

How Q3 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001420506-26-002894 base2026-11-16